Drug Trial Radar · NCT01050829
Gadobutrol Magnevist-controlled Body Study
Last checked: Nov 20, 2026Latest source record: Dec 30, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
370
Actual
Start
Jan 2010
Primary completion
Apr 2011
Study completion Apr 2011
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Jan 15, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to look at the safety (what are the side effects) and efficacy (how well does it work) of gadobutrol when used for taking MR images of the body/extremities regions. The results of the MRI with gadobutrol injection will be compared to the results of MR images taken without contrast and with the results of the MR images taken with Magnevist.
Conditions
- Magnetic Resonance Imaging
Interventions
Gadobutrol (Gadovist, BAY86-4875)Drug
Single administration at a dose of 0.1 mmol/kg
Gadopentetate Dimeglumine (Magnevist, BAY86-4882)Drug
Single administration at a dose of 0.1 mmol/kg
Primary outcomes
What the sponsor says the trial is designed to measure.
- The total score of the following 3 visualization parameters is used for primary variable: Degree of contrast enhancement; Border delineation; Internal morphology.Time frame: At Day 0
Locations
15 sites in 3 countries. Site status is shown where the registry gives one.
Site not named
Beijing, China
Site not named
Shanghai, China
Site not named
Shanghai, China
Site not named
Nanjing, Jiangsu, China
Site not named
Suzhou, Jiangsu, China
Site not named
Xi’an, Shanxi, China
Site not named
Kamogawa, Chiba, Japan
Site not named
Matsuyama, Ehime, Japan
Site not named
Chikushino-shi, Fukuoka, Japan
Site not named
Fukuoka, Fukuoka, Japan
Site not named
Kobe, Hyōgo, Japan
Site not named
Sunto, Shizuoka, Japan
Site not named
Bunkyo-ku, Tokyo, Japan
Site not named
Seoul, South Korea
Site not named
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.